Skip to content

CNO Financial Group stock

CNONYSE

CNO Financial Group, Inc., Financial ServicesISIN US12621E1038

$57.44▼ $0.49 (−0.8%)Closing price of 12 Nov 2026

74Score 74 out of 100, Strong

Turn on early warning

Price and trend

87 / 100

Price history

+38% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 17% above it.

Trend change

Since October 2025 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 66).

Distance to the high

The price is 1.8% below its 52-week high. Largest decline in 20 years: 99% (June 2007 to March 2009).

Chart figures for advanced users
SMA 50$55.00
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$49.23
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)66
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$39.55
The lowest closing price of the last twelve months.
Resistance$58.49
The highest closing price of the last twelve months.
Market cap
$5.29B
Div. yield
1.21%
12 months
13.1
Fair value
$49.30

Snapshot

Computed from the data by fixed rules, no AI

  • CNO Financial Group, Inc. belongs to the Insurance (Life) industry (United States) and, with a market value of $5.25B, is number 29 of 33 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $4.49B (up 0.9% year on year) and earnings of $229.3M (down 43.2%).
  • MEQIRI Score 74 out of 100 (Strong): rank 257 of 976 in Financial Services, median 68.
Show more
  • The P/E is 13 (Insurance (Life) median 11.5, own median of recent years 9.8).
  • Our model puts fair value at $49.30, with the price 17% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Share buybacksShare count down 31% since 2020.Capital allocation 87
  • High return on equityReturn on equity 16.1% over the last 12 months.Profitability 68
  • Reliable dividendNo dividend cut for 14 years.Capital allocation 87

Weaknesses

  • Margin fallingOperating margin 6.5%, average of the prior years 11.7% (to 2024).Profitability 68
74/ 100
MEQIRI Score
Strong

Its standout strengths are momentum and technical analysis.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are strong overall.

Profit consistency90% of years
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)16.1%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What lowers it

  • calm price action
  • solid fundamentals
  • price near its 52-week high

Valuation

Valuation signal

Modestly overvalued
Price
$57.93
Fair value
$49.30
Gap to fair value
+17%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $41.09 and expensive above $61.63 (uncertainty low, based on the price swings of the past year).

The two parts of the fair value come to $47.57 (excess return model) and $51.04 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $45.34, at 7.8% it would be $55.25.

Valuation metrics

2.09
16.1%
last 12 months, profit over average equity
Fair value (model)
$49.30
Earnings part $51.04 (earnings per share $4.43 × 11.5)

Half from the excess return model, half from earnings times the industry P/E (11.5).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 2.3% on the twelve months before. Revenue has stayed largely stable since 2006.

Margins

20 years
  • Operating margin
  • Net margin

In fiscal 2025: operating 7%, net 5%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.

Debt & balance sheet

latest quarter
1.76
Equity
$2.59B
0.07
Cash & equivalents
$9.52B

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
4 Feb 2027in 84 days
Last reported
29 Oct 2026EPS reported $1.90 (expected $1.10)above expectations

Analyst estimates

Fiscal 20262 analysts
Earnings per share
$5.39+13.6%
Revenue
$4.12B+1.3%
Fiscal 20273 analysts
Earnings per share
$5.19+1.9%
Revenue
$4.25B+1.1%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +3.3%

2026 operating earnings per share guidance raised to $4.60 to $4.80 (up 8% at the midpoint) and all other guidance reaffirmed or improved.

Supporting passage from the call, verbatim
“Given our strong first half results, and confidence in the underlying performance of the business, we are increasing our full year operating earnings per share guidance to a range of between $4.60 and $4.80 an 8% increase at the midpoint from our prior 2026 guidance.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 31 Jul 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 5 insiders sold, $7.84M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Williams Jeremy D.Sale

    16 Sept 2026, Chief Actuary

    Shares
    4,362
    Price
    $55.72
    Value
    $243,030
  • Williams Jeremy D.Sale

    15 Sept 2026, Chief Actuary

    Shares
    4,420
    Price
    $55.27
    Value
    $244,292
  • Linnenbringer Jeanne L.Sale

    2 Sept 2026, Chief Operations Officer

    Shares
    3,919
    Price
    $55.11
    Value
    $215,980
Show 10 more
  • DeToro Karen J.Sale

    2 Sept 2026, President, Worksite Division

    Shares
    5,964
    Price
    $55.12
    Value
    $328,729
  • Linnenbringer Jeanne L.Sale

    1 Sept 2026, Chief Operations Officer

    Shares
    4,060
    Price
    $54.73
    Value
    $222,207
  • DeToro Karen J.Sale

    1 Sept 2026, President, Worksite Division

    Shares
    9,336
    Price
    $54.73
    Value
    $511,003
  • Linnenbringer Jeanne L.Sale

    31 Aug 2026, Chief Operations Officer

    Shares
    6,560
    Price
    $54.99
    Value
    $360,716
  • DeToro Karen J.Sale

    31 Aug 2026, President, Worksite Division

    Shares
    9,374
    Price
    $54.98
    Value
    $515,366
  • Tarasi Rocco F. IIISale

    1 Jul 2026, Chief Marketing Officer

    Shares
    1,891
    Price
    $51.31
    Value
    $97,027
  • Bhojwani Gary C.Sale

    30 Jun 2026, Chief Executive Officer

    Shares
    86,048
    Price
    $51.48
    Value
    $4.43M
  • Tarasi Rocco F. IIISale

    11 Jun 2026, Chief Marketing Officer

    Shares
    5,750
    Price
    $50.00
    Value
    $287,500
  • Tarasi Rocco F. IIISale

    10 Jun 2026, Chief Marketing Officer

    Shares
    3,308
    Price
    $49.00
    Value
    $162,092
  • Tarasi Rocco F. IIISale

    2 Jun 2026, Chief Marketing Officer

    Shares
    4,808
    Price
    $47.00
    Value
    $225,976

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at CNO Financial Group

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 257 of 976
257/ 976
This company
74
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies68 (median 57)11 above the median
GrowthMedian of 976 companies60 (median 67)7 below the median
FundamentalsMedian of 976 companies82 (median 80)2 above the median
ValuationMedian of 929 companies with a value55 (median 73)18 below the median
StabilityMedian of 976 companies67 (median 78)11 below the median
Capital allocationMedian of 976 companies87 (median 56)31 above the median
Technical analysisMedian of 976 companies87 (median 70)17 above the median
MomentumMedian of 976 companies89 (median 70)19 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Insurance (Life)

The next larger and next smaller companies by market value

All 33 Insurance (Life) stocks

ETFs that hold CNO Financial Group

Held by 16 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
iShares Ageing Population UCITS ETF2B770.47%0.40%€807M
Avantis Global Small Cap Value UCITS ETFAVWS0.45%0.39%€1.47B
iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG0.18%0.35%€434.1M
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy